Jaswinder J. Singh
PhD program start date: Fall 2016
Expected graduation date: Summer 2021
Current phase of study: Phase III (Thesis)
Research Interests: Corporate Finance: Initial public offerings, mergers and acquisitions, CEO age and gender, characteristics of corporate boards, corporate dividend and share repurchase policy, family firms, insider trading, and performance-based executive incentive compensation. Banking: bank contagion, banking crises and market discipline and bank regulation.
Prior to transitioning to a career in academic finance, Mr. Singh served for 16 years as a pharmacist and pharmacy manager, in both retail and inpatient settings, supervising up to seven employees. He is an expert in pharmacy operations management (optimizing throughput), analytical problem solving, customer service management, inventory management, and training and educating employees, medical professionals and the public. He also worked for two years as a business consultant in accounting and operations management.
- “CEO Gender and Post-IPO Corporate Payout Choice”
- “CEO Gender, Incentive Compensation, and Firm Performance” (with Anup Basnet)
- “Women CEOs, Risk, and Corporate Distribution Policy”
- “Does the Desire to Acquire Drive IPOs?” (Work in progress)
- MBA, University of California at Irvine, 2003
- BScPharm, University of Saskatchewan, 1994
Academic and Teaching Experience
- Research Assistant, Concordia University, Fall 2017 - Winter 2018
- Tutor, Introduction to Finance (COMM 308), Concordia University, Fall, 2017
- Lab Demonstrator, Analytical Pharmaceutical Chemistry, University of Saskatchewan, Fall 1992 - Winter 1993